Sign up
Pharma Capital

Vault Intelligence posts record breaking quarter, adding territories and offerings

Vault Intelligence (ASX:VLT) director Robert Kirtlan speaks to Proactive Investors about the safety technology company's record breaking financial quarter, as well as product development, and ongoing expansion into China and Singapore.

Kirtlan says, "we've seen record sales, we've seen record cash receipts; we're looking to build on that momentum."

The most exciting aspect of research and development currently is the Solo app with wearable technology. "We are working in collaboration with a number of telcos and parties like Samsung who have the wearables. We're really excited about this, it's been a 12-month journey so far, we're nearly there... the interest in the product I would say to you is quite extraordinary," says Kirtlan.


View full VLT profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.